Ingrid Amalie Havnes

  • Researcher, psychiatrist; MD, PhD
 

Publications 2024

Finstad J, Røise O, Clausen T, Rosseland LA, Havnes IA (2024)
A qualitative longitudinal study of traumatic orthopaedic injury survivors' experiences with pain and the long-term recovery trajectory
BMJ Open, 14 (1), e079161
DOI 10.1136/bmjopen-2023-079161, PubMed 38191252

Henriksen HCB, Havnes IA, Jørstad ML, Abdullah R, Thorsby PM, Hauger LE, Edvardsen T, Haugaa KH, Almaas VM, Bjørnebekk A (2024)
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Scand J Med Sci Sports, 34 (1), e14554
DOI 10.1111/sms.14554, PubMed 38268076

Publications 2023

Henriksen HCB, Havnes IA, Jørstad ML, Bjørnebekk A (2023)
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Subst Abuse Treat Prev Policy, 18 (1), 19
DOI 10.1186/s13011-023-00528-z, PubMed 37013635

Scarth M, Westlye LT, Havnes IA, Bjørnebekk A (2023)
Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters
BMC Psychiatry, 23 (1), 342
DOI 10.1186/s12888-023-04781-1, PubMed 37193971

Publications 2022

Bukten A, Lokdam NT, Skjærvø I, Ugelvik T, Skurtveit S, Gabrhelík R, Skardhamar T, Lund IO, Havnes IA, Rognli EB, Chang Z, Fazel S, Friestad C, Hesse M, Lothe J, Ploeg G, Dirkzwager AJE, Clausen T, Tjagvad C, Stavseth MR (2022)
PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study
JMIR Res Protoc, 11 (3), e35182
DOI 10.2196/35182, PubMed 35320114

Finstad J, Clausen T, Rosseland LA, Røise O, Havnes IA (2022)
Patient Experiences after Physical Trauma: The Negative Effect of the COVID-19 Pandemic on Recovery
Int J Environ Res Public Health, 19 (19)
DOI 10.3390/ijerph191912258, PubMed 36231553

Scarth M, Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Westlye LT, Torgersen S, Bjørnebekk A (2022)
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Drug Alcohol Depend, 231, 109275
DOI 10.1016/j.drugalcdep.2022.109275, PubMed 35030506

Publications 2021

Finstad J, Røise O, Rosseland LA, Clausen T, Havnes IA (2021)
Discharge from the trauma centre: exposure to opioids, unmet information needs and lack of follow up-a qualitative study among physical trauma survivors
Scand J Trauma Resusc Emerg Med, 29 (1), 121
DOI 10.1186/s13049-021-00938-7, PubMed 34419130

Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A (2021)
Anabolic androgenic steroids, antisocial personality traits, aggression and violence
Drug Alcohol Depend, 221, 108604
DOI 10.1016/j.drugalcdep.2021.108604, PubMed 33621808

Havnes IA, Muller AE (2021)
Nonprescribed androgen use among women and trans men
Curr Opin Endocrinol Diabetes Obes, 28 (6), 595-603
DOI 10.1097/MED.0000000000000680, PubMed 34709214

Publications 2020

Bukten A, Lund IO, Kinner SA, Rognli EB, Havnes IA, Muller AE, Stavseth MR (2020)
Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
Health Justice, 8 (1), 10
DOI 10.1186/s40352-020-00112-8, PubMed 32399643

Havnes IA (2020)
DOPING Addiction, vanity and performance
Tidsskr. Nor. Laegeforen., 140 (5), 496

Havnes IA, Bukten A, Rognli EB, Muller AE (2020)
Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study
Drug Alcohol Depend, 217, 108255
DOI 10.1016/j.drugalcdep.2020.108255, PubMed 32949884

Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A (2020)
Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects
Int J Drug Policy, 95, 102876
DOI 10.1016/j.drugpo.2020.102876, PubMed 32736958

Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Bjørnebekk A (2020)
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Subst Abuse, 14, 1178221820904150
DOI 10.1177/1178221820904150, PubMed 32127749

Publications 2019

Havnes IA, Jørstad ML, Wisløff C (2019)
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Subst Abuse Treat Prev Policy, 14 (1), 20
DOI 10.1186/s13011-019-0206-5, PubMed 31096999

Pettersen H, Brodahl M, Rundgren J, Davidson L, Havnes IA (2019)
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
Harm Reduct J, 16 (1), 40
DOI 10.1186/s12954-019-0310-x, PubMed 31234878

Publications 2018

Muller AE, Havnes IA, Rognli EB, Bukten A (2018)
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Int J Environ Res Public Health, 15 (12)
DOI 10.3390/ijerph15122663, PubMed 30486386

Publications 2015

Gaasland A, Havnes IA, Venberget M, Andresen JF (2015)
[Re: All suicides are not due to treatment failure]
Tidsskr Nor Laegeforen, 135 (18), 1625
DOI 10.4045/tidsskr.15.0964, PubMed 26442723

Gaasland A, Havnes IA, Venberget M, Andresen JF (2015)
All suicides are not due to treatment failure
Tidsskr. Nor. Laegeforen., 135 (18), 1625

Lie AK, Jensen T, Lichtwarck H, Storaas J, Torjussen E, Havnes IA (2015)
[Putting the patient at the center--already as a student]
Tidsskr Nor Laegeforen, 135 (14), 1236-7
DOI 10.4045/tidsskr.15.0702, PubMed 26269060

Publications 2014

Havnes IA, Clausen T, Brux C, Middelthon AL (2014)
The role of substance use and morality in violent crime - a qualitative study among imprisoned individuals in opioid maintenance treatment
Harm Reduct J, 11, 24
DOI 10.1186/1477-7517-11-24, PubMed 25142321

Havnes IA, Clausen T, Middelthon AL (2014)
Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment
Int J Drug Policy, 25 (3), 480-5
DOI 10.1016/j.drugpo.2014.01.018, PubMed 24594221

Pettersen H, Ruud T, Ravndal E, Havnes I, Landheim A (2014)
Engagement in assertive community treatment as experienced by recovering clients with severe mental illness and concurrent substance use
Int J Ment Health Syst, 8 (1), 40
DOI 10.1186/1752-4458-8-40, PubMed 25389446

Publications 2013

Havnes IA, Clausen T, Middelthon AL (2013)
'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'
Harm Reduct J, 10, 24
DOI 10.1186/1477-7517-10-24, PubMed 24131626

Publications 2012

Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J, Khiabani HZ (2012)
Methadone-related deaths in Norway
Forensic Sci Int, 224 (1-3), 111-6
DOI 10.1016/j.forsciint.2012.11.010, PubMed 23246070

Havnes I, Bukten A, Gossop M, Waal H, Stangeland P, Clausen T (2012)
Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study
Drug Alcohol Depend, 124 (3), 307-10
DOI 10.1016/j.drugalcdep.2012.02.005, PubMed 22382045

Publications 2011

Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T (2011)
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study
Addiction, 107 (2), 393-9
DOI 10.1111/j.1360-0443.2011.03637.x, PubMed 21883606

Bukten A, Skurtveit S, Stangeland P, Gossop M, Willersrud AB, Waal H, Havnes I, Clausen T (2011)
Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study
J Subst Abuse Treat, 41 (4), 407-14
DOI 10.1016/j.jsat.2011.06.006, PubMed 21839605

Publications 2009

Clausen T, Havnes IA, Waal H (2009)
[Overdose statistics--a complicated account]
Tidsskr Nor Laegeforen, 129 (21), 2233-6
DOI 10.4045/tidsskr.08.0605, PubMed 19898571

Publications 2008

Wüsthoff L, Havnes I, Gjersing L, Willersrud A (2008)
[Self-satisfied course leadership--seen from the other side]
Tidsskr Nor Laegeforen, 128 (19), 2224-5; author reply 2225
PubMed 18846152

Page visits: 4739